Bioorganic and Medicinal Chemistry p. 798 - 814 (2018)
Update date:2022-08-04
Topics:
Clarke, Earl
Jarvis, Christopher I.
Goncalves, Maria B.
Kalindjian, S. Barret
Adams, David R.
Brown, Jane T.
Shiers, Jason J.
Taddei, David M.A.
Ravier, Elodie
Barlow, Stephanie
Miller, Iain
Smith, Vanessa
Borthwick, Alan D.
Corcoran, Jonathan P.T.
A ligand-based virtual screening exercise examining likely bioactive conformations of AM 580 (2) and AGN 193836 (3) was used to identify the novel, less lipophilic RARα agonist 4-(3,5-dichloro-4-ethoxybenzamido)benzoic acid 5, which has good selectivity over the RARβ and RARγ receptors. Analysis of the medicinal chemistry parameters of the 3,5-substituents of derivatives of template 5 enabled us to design a class of drug-like molecules with lower intrinsic clearance and higher oral bioavailability which led to the novel RARα agonist 4-(3-chloro-4-ethoxy-5-isopropoxybenzamido)-2-methylbenzoic acid 56 that has high RARα potency and excellent selectivity versus RARβ (2 orders of magnitude) and RARγ (4 orders of magnitude) at both the human and mouse RAR receptors with improved drug-like properties. This RARα specific agonist 56 has high oral bioavailability (>80%) in both mice and dogs with a good PK profile and was shown to be inactive in cytotoxicity and genotoxicity screens.
View MoreContact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Hangzhou yi lu biont technology Co., LTD
Contact:+86-571-88152630
Address:Hangzhoushi HuafengRoad Yicheng3Building1001room.
Contact:+86-571-86025531 / 86024803
Address:1218-24 Guangyin Mansion,42 Fengqi East Road
Onlychem (Jinan)Biotech Co.,Ltd
Contact:86-531-83175885
Address:No. 44, Honglou South Road, Jinan,China
Doi:10.1002/ardp.19903230213
(1990)Doi:10.1039/c0nj00624f
(2011)Doi:10.1002/adsc.202000898
(2020)Doi:10.1021/ol200412r
(2011)Doi:10.1016/S0040-4039(01)80552-9
(1989)Doi:10.1039/c0cc04539j
(2011)